Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity [0.03%]
选择性磷酸二酯酶抑制剂在炎症和自身免疫中的新治疗作用
Diana Hernández-Flórez,Lara Valor
Diana Hernández-Flórez
Myelitis and Lupus: Clinical Manifestations, Diagnosis and Treatment. Review [0.03%]
髓炎和狼疮：临床表现、诊断与治疗综述
Edson Hernán Chiganer,Javier Pablo Hryb,Edgar Carnero Contentti
Edson Hernán Chiganer
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple systems. Myelopathy is one of 19 neuropsychiatric syndromes related to SLE defined by the American College of Rheumatology. Although infrequent, it is ...
Vitamin D and cardiovascular disease in patients with systemic lupus erythematosus [0.03%]
维生素D和系统性红斑狼疮患者的心血管疾病风险关系研究
Mario García-Carrasco,Jose Luis Romero-Galvez
Mario García-Carrasco
María Riestra Fernández,Lorena Suárez Gutiérrez,Mar Martínez et al.
María Riestra Fernández et al.
Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate [0.03%]
一名正在接受甲氨蝶呤治疗的类风湿关节炎患者出现内脏利什曼病
Delia Reina,Dacia Cerdà,Elena Güell et al.
Delia Reina et al.
Patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic drugs are susceptible to severe infections such as leishmaniasis. As L. infantum is endemic in the Mediterranean region, it is necessary to rule this infec...
Isla Morante Bolado,Marina Ortega Navaridas,Daniel Clemente Garulo et al.
Isla Morante Bolado et al.
Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases [0.03%]
长期生物制剂治疗大血管炎的持续缓解：10例分析
Juan P Vinicki,Rosario García-Vicuña,Miguel Arredondo et al.
Juan P Vinicki et al.
Objectives: To describe the results obtained in clinical practice with the use of biological therapy (BT) in patients diagnosed with Takayasu arteritis (TA) and giant cell arteritis (GCA). ...
Paolo Cariati,Fernando Monsalve Iglesias,José Fernández Solís et al.
Paolo Cariati et al.
Cherubism is a rare disorder with autosomal dominant inheritance. It is classified as a benign fibro-osseous lesions and may involve either facial bone. Its typical dentofacial deformities are caused by mutations in the SH3BP2 gene. The pro...
How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis? [0.03%]
风湿性疾病且使用TNF抑制剂治疗的患者中潜在结核病的比例是多少？
Noemi Busquets-Pérez,Andrés Ponce,Vera Ortiz-Santamaria et al.
Noemi Busquets-Pérez et al.
Objectives: Spanish clinical guidelines recommend screening patients for tuberculosis (TB) before TNF inhibitors (TNFi) treatment. Our objective was to estimate the prevalence of TST seroconversion as an estimation of the...
Marta Novella Navarro,María Del Mar Muñoz Gómez,Juan Salvatierra Ossorio
Marta Novella Navarro